| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.27 | 7e-07 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.18 | 2e-06 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.23 | 3e-05 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | 0.13 | 8e-05 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0007 |